SynthesisFrontiers in oncology2026

Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis.

Ejike Daniel Eze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.